Below are the most recent publications written about "Ticlopidine" by people in Profiles.
-
Kotronias RA, Kwok CS, Wong CW, Kinnaird T, Zaman A, Mamas MA. Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis. Drug Saf. 2017 03; 40(3):229-240.
-
Lopes RD, Rao M, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey P, Piccini JP, Singer DE, Chang P, Peterson ED, Mahaffey KW. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med. 2016 06; 129(6):592-599.e1.
-
Amico F, Amico A, Mazzoni J, Moshiyakhov M, Tamparo W. The evolution of dual antiplatelet therapy in the setting of acute coronary syndrome: ticagrelor versus clopidogrel. Postgrad Med. 2016; 128(2):159-63.
-
Mizrahi E, Suryadevara RS, Barn K, Boga G, Akram MM, Ismail-Sayed I, Henry YM, Troup MA, Berger PB. Impact of Switching From Prasugrel to Clopidogrel Shortly After a Percutaneous Coronary Intervention Without a Loading Dose of Clopidogrel. J Invasive Cardiol. 2015 Dec; 27(12):543-6.
-
Dias A, Franco E, Koshkelashvili N, Bhalla V, Pressman GS, Hebert K, Figueredo VM. Antiplatelet therapy in Takotsubo cardiomyopathy: does it improve cardiovascular outcomes during index event? Heart Vessels. 2016 Aug; 31(8):1285-90.
-
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P, van Eickels M, Lip GY, Cohen M, Husted S, Peterson E, Fox K. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). Am Heart J. 2015 Apr; 169(4):472-8.e5.
-
Tai WA, Albers GW. Secondary prevention of atherothrombotic or cryptogenic stroke. Circulation. 2014 Jan 28; 129(4):527-31.
-
Ice DS, Shapiro TA, Gnall EM, Kowey PR. Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. Am J Cardiol. 2014 Mar 01; 113(5):888-96.
-
Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L, Ezekowitz MD, Ansell J, Kowey P, Singer DE, Gersh B, Mahaffey KW, Hylek E, Go AS, Chang P, Peterson ED. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8.
-
Mahaney KB, Chalouhi N, Viljoen S, Smietana J, Kung DK, Jabbour P, Bulsara KR, Howard M, Hasan DM. Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy. J Neurosurg. 2013 Oct; 119(4):937-42.